Finance Watch: Bausch + Lomb Completes Split From Bausch Health Via IPO
PepGen Went Public On 5 May As Well
Public Company Edition: Bausch remains the majority shareholder, but B+L is a separate operating company. Also, Rezolute raises $130m in dual financings and BridgeBio outlines job cuts and will out-license assets to conserve cash.
